Pharmacy Today 

 - New York :  Elsevier, Inc.,  c2021. 
 - 64 pages :  color illustrations ;  27 cm. 
 -  Pharmacy Today, Volume 27, Issue 3, March 2021 .
<br/><br/>Includes bibliographical references. 
<br/><br/>New & Approved: New drugs, indication -- On the Shelf: melatonin and sleep -- OTCs Today: Intestinal gas -- Cabenuva: Once-monthly drug for adults with HIV -- Immunization Update: Shared decision-making for pregnant patients seeking COVID-19 vaccinations -- At-Home COVID-19 Tests -- Asthma Guidelines -- Innovations -- Error Alert -- 340B -- COVID-19 Vaccines -- Vintage Pharmacy -- Inpatient insights -- Antithrombotic therapy -- COVID-19 -- Compounding drug guidelines -- Perioperative Opioid use -- On the docket -- Policy Roundup. 
<br/><br/> [Article Title: Melatonin for sound sleep / Mickie Cathers, managing editor, p. 13]<br/><br/>Abstract: An estimated 50 to 70 million Americans suffer from sleep disorders or sleep deprivation. Poor sleep can have far-reaching consequences, including energy depletion, lowered productivity, and an increase in the risk of cardiovascular diseases.  [Article Title: Intestinal Gas / Daniel L. Krinsky, p. 14]<br/><br/>Abstract: Intestinal gas-related symptoms and conditions that predispose affected patients to intestinal gas aare common and may cause considerable discomfort and lifestyle impairment.  [Article Title: FDA approves first once-monthly injectable drug regimen for adults with HIV / Cara Aldridge Young, 15]<br/><br/>Abstract: Adults living with HIV infection can choose to receive once-monthly injections in lieu of a daily oral treatment regimen with FDA's approval of Cadenuva (ViiV Healthcare). The new regimen consists of a copack with two injectable medications- Viiv Healthcare's cabotegravir and Janssen's rilpivirine- to offer a replacement option for patients who are virologically suppressed on their current antiretroviral regimen.  [Article Title: Use shared decision-making when offering COVID-19 vaccine to pregnant patients / Loren Bonner, editor, p. 16-17]<br/><br/>Abstract: While neither Pfizer nor Moderna included pregnant individuals in their COVID-19 vaccine trials, data suggest that pregnant patients are at a higher risk of severe COVID-19 infection compared with nonpregenant women.  [Article Title: Rapid-at-home tests: Huge advancement in health care-or false sense of security? / Clarrisa Chan, p. 18-19]<br/><br/>Abstract: At the beginning of the pandemic, many COVID-19 cases are largely went undetected, which made it difficult to prevent and slow the spread of the virus. Originally, home testing results typically has slower turnaround times of a few days because samples were shipped to labs for analysis.  [Article Title: Update to asthma guidelines covers ICS, LAMAs, indoor allergy mitigation, more / Maria G. Tanzi, p. 24]<br/><br/>Abstract: In december 2020, The national asthma education and prevention program (NAEPP) coordinating committee released a focused update to its 2007 asthma guidelines. The update covers only select topics, such as intermittent use of inhaled corticosteroids (ICS), the role of long-acting muscarinic antagonists (LAMAs), indoor allergy mitigation, use of immunotherapy, bronchial thermoplasty, and gractional exhaled nitric oxide (FeNO) testing.  [Article Title: A valued profession in the face of COVID-19 / Loren Bonner, editor p. 26-35]<br/><br/>Abstract: Since the pandemic hit roughly 1 year ago, we've heard about the many ways pharmacists are contributing and being recognized for their remarkable efforts to help patients and communities.  [Article Title: Anatomy of a conventional vs. liposomal doxorubicin mix-up / Institute for safe medication practices, p. 36]<br/><br/>Abstract: Since 1996, the Institute for safe medication practices (ISMP) has warned about accidental administration of doxorubicin liposomal injection (Doxil) instead of the conventional form, doxorubicin injection solution or lyophilized powder (Adriamycin).  [Article Title: Ongoing dispute between drug makers, 340B-covered entities far from over / Sonya Collins, p. 37-38]<br/><br/>Abstract: Last december, novo nordisk joined five other drug makers- Eli Lily, AstraZeneca, Merck, Sanofi, and Novartis- in its announcement that it would halt 340B discounts to contract pharmacies, effective January 1.  [Article Title: New guidance focuses on optimal antithrombotic therapy for patients with AF, VTE / Maria G. Tanzi, p. 41]<br/><br/>Abstract: In late 2020, the American College of Cardiology (ACC) published an expert consensus decision pathway in the Journal of the American College of Cardiology (JACC) on the use of optimal antithrombotic therapy for patients who are already receiving either an anticoagulant or antiplatelet therapy and subsequently develop another condition requiring additional antithrombotic therapy.  [Article Title: COVID-19 vs. Influenza: An outclassed outbreak / Corey Diamond, p.42]<br/><br/>Abstract: Since the beginning of the COVID-19 pandemic, SARS-CoV-2 has naturally been compared to seasonal influenza.  [Article Title: FDA updates guidelines to protect patients from poor-quality compounding / Joey Sweeney, p. 43]<br/><br/>Abstract: FDA released final guidance to protect patients form exposure to what the agency called "poor-quality compounded drugs". The 15-page document seeks to combat insanitary conditions-many witnessed firsthand during inspections-at 503B compounding facilities.  [Article Title: Consitent education, use of opioidsparing regimens can reduce misuse among kids having surgery / Rachel Balick, p. 44-45]<br/><br/>Abstract: After a comprehensive literature review, the american pediatric surgical association (APSA) outcomes and evidence-based practice committee, along with a panel of health care and opioid stewardship leaders, issued 20 recommendations on perioperative use of opioids in children ages 18 years and younger.  [Article Title: CDC clears up questions about COVID-19 vaccine dosage intervals, interchangeability / Rachel Balick, p. 46]<br/><br/>Abstract: Revised CDC clinical recommendations specify the intervals of 6 weeks between mRNA COVID-19 vaccine doses are OK when delays are unavoidable and that the Pfizer-BioNTech and Moderna vaccines are not interchangeable, barring exceptional circumstances.  [Article Title: Vintage pharmacy artifacts reveal history of phramacy / Mickie Cathers, p. 47-48]<br/><br/>Abstract: Howard Sanford of Miami, FL, is a retired physician, with a pharmacy degree from Columbia University. "Working in my father's pharmacy, I inherited some of his collection of early 20th- century pharmacy pieces, " said Sanford, MD.  [Article Title: Patient lawsuit against hospital pharmacy reveals necessity of documentation / David B. Brushwood, p. 49]<br/><br/>Abstract: Pharmacists have a legal responsibility to protect patients from harm that is due to drug overdosage. In meeting this responsibility, pharmacists must verbally consult with the medical staff and document the consultation.  [Article Title: Insulin and epinephrine auto-injector prices, rebate rule delay, and more / Rachel Balick, p. 50-51]<br/><br/>Abstract: As expected, President Joseph R. Biden issued a regulatory freeze on Donald J. Trump administration rules and guidances that had not yet taken effect or had not been finalized when the former president left office.  [Article Title: Pharmacists' role during the COVID-19 pandemic / Maria G. Tanzi, p.54-62]<br/><br/>Abstract: The COVID-19 pandemic has changed the way health care is routinely delivered, with pharmacists taking a lead role in meeting individual patient needs across practice settings. 
<br/><br/><label>ISSN: </label>1042-0991